Summary of Key Points Core Viewpoint - The company has announced the progress of its entrusted wealth management using idle raised funds, indicating a strategic approach to optimize fund allocation and enhance investment returns while ensuring that the main business operations remain unaffected [1][2]. Group 1: Wealth Management Details - The company has approved the use of idle raised funds for wealth management, with a maximum limit of 219 million yuan, valid for 12 months from the board's approval date [2]. - The company has purchased a structured deposit product named "智汇系列进取型看涨三层区间 59 天结构性存款" from China Merchants Bank for 10 million yuan, with a term of 59 days [1][4]. - Additionally, the company has invested 9 million yuan in a structured deposit product from Shanghai Pudong Development Bank, with a term of 29 days [1][4]. Group 2: Financial Impact and Measures - The investment in short-term wealth management products is expected to generate certain investment returns, thereby enhancing the company's performance and providing better returns for shareholders [5]. - The company emphasizes that the wealth management products chosen are of high safety, good liquidity, and low risk, ensuring that the investment does not affect the normal operation of the company's main business [5]. - The company will conduct audits on the investment situation and report any issues to the audit committee promptly [5].

Summary of Key Points Core Viewpoint The announcements from Yifeng Pharmacy Chain Co., Ltd. detail the status of its convertible bonds and the management of idle raised funds through financial products, indicating a strategic approach to enhance financial efficiency and shareholder returns. Group 1: Convertible Bond Conversion Status - As of June 30, 2025, a total face value of 163,000 yuan of "Yifeng Convertible Bonds" has been converted into 4,950 shares of the company's A-shares, representing 0.0004% of the total shares before conversion [2][4]. - The remaining unconverted "Yifeng Convertible Bonds" have a face value of 1,797,269,000 yuan, accounting for 99.9909% of the total issuance [2][4]. - During the quarter from April 1, 2025, to June 30, 2025, 2,000 yuan of "Yifeng Convertible Bonds" were converted into 60 shares [2][4]. Group 2: Convertible Bond Issuance Overview - The company issued 17,974,320 convertible bonds with a total face value of 179,743.20 million yuan, approved by the China Securities Regulatory Commission on March 4, 2024 [3]. - The bonds were listed on the Shanghai Stock Exchange on March 27, 2024, and can be converted into shares starting from September 9, 2024 [3]. Group 3: Management of Idle Funds - The company redeemed structured deposits totaling 10,300.00 million yuan and plans to continue investing 11,400.00 million yuan in new financial products [6][8]. - The board approved the use of up to 30,000.00 million yuan of idle raised funds for financial investments, ensuring that it does not affect the normal operation of investment projects [6][10]. - The investment strategy aims to enhance the efficiency of idle funds and increase company returns without impacting daily operations [13].